141 related articles for article (PubMed ID: 38396785)
1. Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives.
Fernandes S; Vieira M; Prudêncio C; Ferraz R
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396785
[TBL] [Abstract][Full Text] [Related]
2. Triphenylphosphonium Analogues of Betulin and Betulinic Acid with Biological Activity: A Comprehensive Review.
Grymel M; Zawojak M; Adamek J
J Nat Prod; 2019 Jun; 82(6):1719-1730. PubMed ID: 31141361
[TBL] [Abstract][Full Text] [Related]
3. Betulinic acid: a promising anticancer candidate.
Eiznhamer DA; Xu ZQ
IDrugs; 2004 Apr; 7(4):359-73. PubMed ID: 15057642
[TBL] [Abstract][Full Text] [Related]
4. New Pharmacological Opportunities for Betulinic Acid.
Ríos JL; Máñez S
Planta Med; 2018 Jan; 84(1):8-19. PubMed ID: 29202513
[TBL] [Abstract][Full Text] [Related]
5. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection.
Cichewicz RH; Kouzi SA
Med Res Rev; 2004 Jan; 24(1):90-114. PubMed ID: 14595673
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
Shi W; Tang N; Yan WD
J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
[TBL] [Abstract][Full Text] [Related]
7. Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells.
Jeremias I; Steiner HH; Benner A; Debatin KM; Herold-Mende C
Acta Neurochir (Wien); 2004 Jul; 146(7):721-9. PubMed ID: 15197616
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the divergent activities of betulinic acid via neoglycosylation.
Goff RD; Thorson JS
Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
[TBL] [Abstract][Full Text] [Related]
9. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
10. Terpene Esters from Natural Products: Synthesis and Evaluation of Cytotoxic Activity.
Victor MM; David JM; Sakukuma MCK; Costa-Lotufo LV; Moura AF; Araújo AJ
An Acad Bras Cienc; 2017; 89(3):1369-1379. PubMed ID: 28813102
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Betulinic Acid-Cisplatin conjugate APC and its precursor DE9B for the treatment of human malignant glioma.
Bache M; Hein A; Petrenko M; Güttler A; Keßler J; Wichmann H; Kappler M; Emmerich D; Paschke R; Vordermark D
Chem Biol Interact; 2019 Dec; 314():108841. PubMed ID: 31586452
[TBL] [Abstract][Full Text] [Related]
12. A Review on Preparation of Betulinic Acid and Its Biological Activities.
Lou H; Li H; Zhang S; Lu H; Chen Q
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577056
[TBL] [Abstract][Full Text] [Related]
13. Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.
Valdés K; Morales J; Rodríguez L; Günther G
Nanomedicine (Lond); 2016 Dec; 11(23):3139-3156. PubMed ID: 27809705
[TBL] [Abstract][Full Text] [Related]
14. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
Fulda S; Jeremias I; Steiner HH; Pietsch T; Debatin KM
Int J Cancer; 1999 Jul; 82(3):435-41. PubMed ID: 10399962
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia.
Waechter F; da Silva GNS; Willig JB; de Oliveira CB; Vieira BD; Trivella DBB; Zimmer AR; Buffon A; Pilger DA; Gnoatto SCB
Anticancer Agents Med Chem; 2017; 17(13):1777-1785. PubMed ID: 28403779
[TBL] [Abstract][Full Text] [Related]
16. [Biological activity and pharmacological prospects of lupane terpenoids: I. Natural lupane derivatives].
Tolstikova TG; Sorokina IV; Tolstikov GA; Tolstikov AG; Flekhter OB
Bioorg Khim; 2006; 32(1):42-55. PubMed ID: 16523720
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of betulinic acid derivatives with activity against human melanoma.
Kim DS; Pezzuto JM; Pisha E
Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
[TBL] [Abstract][Full Text] [Related]
19. A Review of Electroporation-based Antitumor Skin Therapies and Investigation of Betulinic Acid-loaded Ointment.
Bakonyi M; Berko S; Eros G; Varju G; Dehelean CA; Budai-Szucs M; Csanyi E
Anticancer Agents Med Chem; 2018; 18(5):693-701. PubMed ID: 29141562
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors.
Fulda S; Jeremias I; Pietsch T; Debatin KM
Klin Padiatr; 1999; 211(4):319-22. PubMed ID: 10472570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
